Two senior physicians and co-founders of Fullerton Healthcare Corporation have been ordered to pay combined penalties of S$160,000 after admitting to falsifying corporate entertainment accounts in a scheme spanning multiple years. Daniel Chan Pai Sheng and Michael Tan Kim Song, both aged 52, pleaded guilty to their respective charges on July 8 and were sentenced on Friday, July 10.
The case reveals an intricate operation designed not to enrich the perpetrators but rather to funnel corporate funds to Collin Chiew, a former insurance broker executive who had approached Chan for financial assistance around 2015. Court documents indicate Chiew, who previously served as chief executive of Aon Singapore between January 2015 and July 2018, requested help covering personal expenses including children's education and housing costs. The total amount funnelled through falsified entertainment claims exceeded S$211,000, though documents do not confirm whether Chiew ultimately received the full amount.
Chan bore primary responsibility within the conspiracy, pleading guilty to five counts of falsification of accounts. His fabricated entertainment expenses totalled more than S$336,000 against actual costs of approximately S$125,000, representing an inflation of over S$211,000. He received the heavier fine of S$135,000. Tan's involvement was more limited, with a single count relating to one of Chan's offences. His falsified claim amounted to approximately S$82,000 against actual expenses exceeding S$42,000, an inflated margin of nearly S$40,000, resulting in a S$25,000 fine.
The scheme operated with sophisticated mechanics across multiple jurisdictions. Chan regularly travelled to Hong Kong for legitimate business purposes, visiting approximately twice monthly beginning in 2015 to facilitate FHC operations in that market. Before each trip, he would inform David Sin, a third co-founder who has separately pleaded guilty to related offences, that inflated or entirely false Karaoke Television receipts were required. Tei Chu Pink, a 46-year-old associate, prepared these falsified documents. Upon arrival in Hong Kong, Chan would present himself at various KTV establishments alongside Sin and Tei, ostensibly engaging with potential investors and conducting entertainment-based business development. However, his actual payments bore little resemblance to the inflated receipts subsequently collected.
In numerous instances, Chan deliberately underpaid or avoided payment entirely at these venues, using minimal personal cash or credit card transactions that bore no correlation to the falsified receipts provided by Tei. Upon returning to Singapore, he deliberately transmitted these fabricated documents to designated persons within FHC's corporate structure or its subsidiary Fullerton Health China. These individuals then processed the claims through normal channels, enabling the extraction of funds that were ultimately diverted toward Chiew's personal requirements. The operation achieved its deceptive purpose through routine corporate financial processes, with Michael Tan's knowledge and occasional participation lending apparent legitimacy to the transactions.
The prosecution authorities also identified evidence of direct conspiracy among the three co-founders. In 2016, Tan, Chan, and Sin engaged in a coordinated falsification involving a single entertainment claim, demonstrating deliberate and joint criminal intent rather than isolated misconduct. This collaborative element strengthened the case against all parties, establishing that falsification was not incidental to business travel but rather a deliberate mechanism constructed by the company's leadership.
Chan's departure from FHC was prompted by his conviction, with court documents confirming he no longer holds positions within the company or its subsidiaries. Tan similarly relinquished his directorship of Fullerton Healthcare Group, the principal operating subsidiary that Chan and Tan had established in 2010. That entity provided healthcare services through an extensive network of physicians and medical specialists, while simultaneously assisting clients with insurance claim processing—a function that created opportunities to divert corporate resources given the complexity of financial flows within such operations. Fullerton Health China, a further subsidiary where Chan held the presidency, also terminated his engagement following the guilty pleas.
David Sin, the third co-founder, preceded the others through the court system. In August 2025, Sin, aged 47, pleaded guilty to six counts of falsification of accounts and received an identical S$160,000 fine to that imposed on Chan and Tan combined. Sin's separate involvement underscores how pervasively falsification had infiltrated the company's financial controls across multiple senior levels.
Notably, both Chan and Tan initially faced multiple corruption-related charges under Singapore's Prevention of Corruption Act. However, prosecutors exercised discretionary authority to withdraw these more serious allegations on July 10. Deputy public prosecutors Jonathan Tan and Ashley Chin filed applications for discharge not amounting to acquittal, citing prosecutorial discretion as the basis. While such discharges spare the defendants immediate conviction on those charges, they preserve the Crown's legal capacity to reinstitute prosecution if substantive new evidence emerges. This prosecutorial restraint suggests investigators may lack sufficient evidence to sustain corruption convictions despite apparent consciousness of guilt evident in the falsification admissions.
The case illuminates vulnerabilities in corporate governance structures within healthcare and professional services organizations, particularly those with international operations. The ability of senior executives to manipulate expense documentation across multiple jurisdictions, combined with the routine processing of these falsified claims by subordinate staff, demonstrates how organizational complexity can facilitate fraud. Malaysian healthcare operators and healthcare investment groups maintaining regional presences should consider whether similar conditions exist within their own financial controls and whether middle management sufficiently scrutinizes entertainment and travel claims originating from senior executives with international responsibilities.
FHC operates as an investment holding company within Singapore's competitive healthcare sector, positioning it as a significant player in the region's medical services market. The conviction of its co-founders creates reputational implications extending beyond regulatory compliance, potentially affecting client relationships and market positioning. The scheme's focus on deflecting funds toward Chiew's personal benefit rather than enriching the founders themselves presents an interesting psychological dimension—suggesting that facilitating a colleague's financial distress may have motivated corporate crimes that enriched no one internally, a cautionary pattern for Southeast Asian businesses where personal relationships often intersect with professional obligations.
